Form 8-K - Current report:
SEC Accession No. 0000950170-24-064559
Filing Date
2024-05-24
Accepted
2024-05-24 16:05:23
Documents
12
Period of Report
2024-05-23
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20240523.htm   iXBRL 8-K 61978
2 EX-3.1 lbph-ex3_1.htm EX-3.1 11732
  Complete submission text file 0000950170-24-064559.txt   206341

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lbph-20240523.xsd EX-101.SCH 32545
15 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20240523_htm.xml XML 5114
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

EIN.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 24984235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)